probenecid has been researched along with Autoimmune Diabetes in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engler, CB | 1 |
Sander, B | 1 |
Larsen, M | 1 |
Koefoed, P | 1 |
Parving, HH | 1 |
Lund-Andersen, H | 1 |
Magoula, I | 1 |
Tsapas, G | 1 |
Paletas, K | 1 |
Mavromatidis, K | 1 |
1 trial available for probenecid and Autoimmune Diabetes
Article | Year |
---|---|
Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
Topics: Adult; Biological Transport, Active; Blood; Blood-Retinal Barrier; Capillary Permeability; Cross-Ove | 1994 |
1 other study available for probenecid and Autoimmune Diabetes
Article | Year |
---|---|
Insulin-dependent diabetes and renal hypouricemia.
Topics: Adolescent; Adult; Creatinine; Diabetes Mellitus, Type 1; Female; Humans; Kidney Tubules; Male; Prob | 1991 |